Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Financial Flexibility Index
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥174.25 Million (operating CF CN¥117.38 Million minus capex CN¥56.87 Million) represents 0% of total liabilities (CN¥2.44 Billion). Check 600436 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Zhangzhou Pientzehuang Pharmaceutical Co.
Annual Financial Flexibility Index for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year free cash flow to debt coverage for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. Explore Zhangzhou Pientzehuang Pharmaceutical Co debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | CN¥416.82 Million | CN¥77.03 Million | CN¥2.47 Billion | ▼ -80.9% |
| 2024 | 0.88x | CN¥2.38 Billion | CN¥1.31 Billion | CN¥2.70 Billion | ▲ +18.7% |
| 2023 | 0.74x | CN¥2.35 Billion | CN¥2.21 Billion | CN¥3.16 Billion | ▼ -70.7% |
| 2022 | 2.54x | CN¥7.05 Billion | CN¥6.87 Billion | CN¥2.78 Billion | ▲ +978.6% |
| 2021 | 0.24x | CN¥554.44 Million | CN¥462.27 Million | CN¥2.36 Billion | ▼ -75.7% |
| 2020 | 0.97x | CN¥1.89 Billion | CN¥1.47 Billion | CN¥1.95 Billion | ▲ +318.9% |
| 2019 | -0.44x | CN¥-813.94 Million | CN¥-879.37 Million | CN¥1.84 Billion | ▼ -186.9% |
| 2018 | 0.51x | CN¥686.55 Million | CN¥612.31 Million | CN¥1.35 Billion | ▼ -14.7% |
| 2017 | 0.60x | CN¥728.80 Million | CN¥676.93 Million | CN¥1.22 Billion | ▲ +58.0% |
| 2016 | 0.38x | CN¥485.51 Million | CN¥394.54 Million | CN¥1.29 Billion | ▼ -26.2% |
| 2015 | 0.51x | CN¥384.37 Million | CN¥305.51 Million | CN¥751.60 Million | ▲ +16.7% |
| 2014 | 0.44x | CN¥290.36 Million | CN¥264.50 Million | CN¥662.34 Million | ▼ -30.5% |
| 2013 | 0.63x | CN¥420.88 Million | CN¥274.34 Million | CN¥667.05 Million | ▲ +34.1% |
| 2012 | 0.47x | CN¥317.62 Million | CN¥162.40 Million | CN¥675.22 Million | ▼ -33.5% |
| 2011 | 0.71x | CN¥268.51 Million | CN¥232.95 Million | CN¥379.69 Million | ▲ +5.1% |
| 2010 | 0.67x | CN¥244.31 Million | CN¥205.41 Million | CN¥362.97 Million | ▲ +80.7% |
| 2009 | 0.37x | CN¥159.19 Million | CN¥129.52 Million | CN¥427.35 Million | ▲ +66.9% |
| 2008 | 0.22x | CN¥71.08 Million | CN¥12.57 Million | CN¥318.45 Million | ▼ -71.6% |
| 2007 | 0.79x | CN¥166.50 Million | CN¥60.04 Million | CN¥212.03 Million | ▲ +44.8% |
| 2006 | 0.54x | CN¥59.41 Million | CN¥50.70 Million | CN¥109.53 Million | ▼ -55.2% |
| 2005 | 1.21x | CN¥103.59 Million | CN¥69.06 Million | CN¥85.56 Million | ▼ -78.2% |
| 2004 | 5.56x | CN¥109.42 Million | CN¥98.67 Million | CN¥19.69 Million | ▲ +380.1% |
| 2003 | 1.16x | CN¥47.92 Million | CN¥32.36 Million | CN¥41.40 Million | ▲ +71.8% |
| 2002 | 0.67x | CN¥115.22 Million | CN¥105.45 Million | CN¥170.99 Million | ▲ +8.1% |
| 2001 | 0.62x | CN¥77.49 Million | CN¥65.84 Million | CN¥124.34 Million | — |